Continued testing H5N1 vaccine on humans
Sunday, 09/18/2011 22:54
(NLD) - After the second injection stage clinical trials of influenza A/H5N1 vaccine on volunteers to succeed, the Ministry of Health has approved the expansion of clinical trials for this vaccine
This test phase will be carried out on 1,000 healthy volunteers. Previously, this vaccine has been tested in phase 1 and 2 500 volunteers. Test results of the recent period for good results, the protective effect of over 90%, no severe reactions in people vaccinated.
When the testing is complete, reaching the required standards for human use, this new vaccine is licensed for circulation. Influenza A/H5N1 vaccine by scientists from the company production of vaccines and biologicals No. 1 (Institute of Hygiene and Epidemiology) study, produced from monkey kidney cells in 2004.
No comments:
Post a Comment